Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

299
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
299
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

412
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
412
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.4K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Technical advances in robotic retinal surgery: a systematic review and future research directions.

Journal of robotic surgery·2026
Same author

Not Just Another Deep Vein Thrombosis: Unmasking May-Thurner Syndrome.

Cureus·2026
Same author

1,3,4 oxadiazole derivative attenuates neurotransmitter-mediated inflammatory response in EAE model of multiple sclerosis.

Scientific reports·2026
Same author

Rifampicin population pharmacokinetics and pharmacogenomic evaluation of SLCO1B1 gene in tuberculosis patients.

The Indian journal of tuberculosis·2026
Same author

Technical advances in robotic retinal surgery: a systematic review and future research directions.

Journal of robotic surgery·2026
Same author

Clinical outcomes of pulmonary tuberculosis two years later in children treated with daily regimen of antitubercular drugs.

The Indian journal of tuberculosis·2026
Same journal

MICROSCOPY: NOT THE LOST ART - INVISIBLE INVADER OF THE URINARY TRACT!

Indian journal of medical microbiology·2026
Same journal

Rapid and Accurate Identification of Nontuberculous Mycobacteria (NTM) by MALDI-TOF MS using a Modified Extraction Protocol.

Indian journal of medical microbiology·2026
Same journal

NONTUBERCULOUS MYCOBACTERIA IN INDIA: SPECIES DISTRIBUTION AND SUSCEPTIBILITY COMPARED WITH WESTERN DATA.

Indian journal of medical microbiology·2026
Same journal

Multicenter Study on Blood Culture Quality and Turnaround Time of Patients in Intensive Care Unit in Guangdong Province, China.

Indian journal of medical microbiology·2026
Same journal

Study of tedizolid susceptibility among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections, eastern India.

Indian journal of medical microbiology·2026
Same journal

Unmasking Neuroinvasive Melioidosis: Insights from Burkholderia pseudomallei Cases in an Indian Neurocenter - A Case Series.

Indian journal of medical microbiology·2026
See all related articles

Related Experiment Video

Updated: Aug 20, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.2K

National TB elimination programme - What has changed.

Ashwani Khanna1, Rumpa Saha2, Nadeem Ahmad2

  • 1Government of Delhi, India.

Indian Journal of Medical Microbiology
|November 19, 2022
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) remains a significant global health threat, but it is curable and preventable with effective drug regimens. Advancements in diagnostics, drugs, and vaccines are crucial for reducing TB incidence worldwide.

Keywords:
CBNAATNSP 2020–25TrueNat MTBTuberculosis

More Related Videos

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

301
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

Related Experiment Videos

Last Updated: Aug 20, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.2K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

301
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Tuberculosis (TB) was a leading cause of death from a single infectious agent before COVID-19.
  • Approximately 25% of the global population is infected with Mycobacterium tuberculosis.
  • TB is a curable and preventable disease, with an 85% success rate for treatment using 6-month drug regimens.

Purpose of the Study:

  • To outline the evolution and changes in India's National TB Elimination Programme.
  • To assess the progress and challenges in TB control in India.
  • To highlight the strategies for TB elimination in India.

Main Methods:

  • Review of the historical development of the National TB Programme in India since 1962.
  • Analysis of the National Strategic Plans for Tuberculosis Elimination (2017-25 and 2025).
  • Examination of India's current preparedness and interventions for TB control.

Main Results:

  • India launched its National TB Programme in 1962, evolving significantly over decades.
  • The National Strategic Plan (2017-25) aimed for TB elimination by 2025, but revised targets were set with NSP India 2025 in 2020.
  • Despite ongoing challenges, India has enhanced its capacity with advanced diagnostic and treatment interventions for TB.

Conclusions:

  • India has a long history of TB control efforts, with ongoing strategic planning for elimination.
  • The country is better equipped to combat TB due to improved interventions and technologies.
  • Continued focus on advanced diagnostics, treatment, and universal health coverage is essential for TB elimination.